This inventor holds 1 USPTO granted patent. Top assignee: Teva Pharmaceuticals International Gmbh. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Jason Clevenger: Innovator in Iontophoretic Drug Delivery Systems
Introduction
Jason Clevenger is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of drug delivery systems, particularly through his innovative patent related to iontophoretic devices. His work focuses on enhancing the effectiveness and reliability of therapeutic agent administration.
Latest Patents
Clevenger holds a patent titled "Detection of presence and alignment of a therapeutic agent in an iontophoretic drug delivery device." This patent describes a system designed to test whether an iontophoretic drug delivery device is in an appropriate state for administering a therapeutic agent into an animal body. The system utilizes an electrical characteristic of at least one electrical path associated with an electrode test point to determine the device's readiness. When the therapeutic agent is properly aligned with respect to the electrodes, the measured electrical characteristic indicates that the device is suitable for administration.
Career Highlights
Jason Clevenger is currently employed at Teva Pharmaceuticals International GmbH, where he continues to develop innovative solutions in the pharmaceutical industry. His expertise in drug delivery systems has positioned him as a valuable asset to his team and the company.
Collaborations
Clevenger collaborates with talented professionals, including Ronalee Lo Mann and David Saar. Their combined efforts contribute to the advancement of drug delivery technologies and improve patient outcomes.
Conclusion
Jason Clevenger's work in the field of iontophoretic drug delivery systems exemplifies the impact of innovation in healthcare. His patent and ongoing contributions at Teva Pharmaceuticals International GmbH highlight his commitment to improving therapeutic administration methods.